Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
HonorHealth Research Institute
HonorHealth Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yale University
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center at San Antonio
Columbia University
Emory University
University of Washington
M.D. Anderson Cancer Center
Emory University
University of Kentucky
Merck Sharp & Dohme LLC
Lahey Clinic
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Tempus AI
Medical College of Wisconsin
Day One Biopharmaceuticals, Inc.
Institut Bergonié
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Mayo Clinic
University of California, San Diego
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Colorado, Denver
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OHSU Knight Cancer Institute
Washington University School of Medicine
Thomas Jefferson University
M.D. Anderson Cancer Center
Elevation Oncology
BPGbio
Redx Pharma Ltd
Georgetown University
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoosier Cancer Research Network
Dana-Farber Cancer Institute
Bruckner Oncology
National Cancer Institute (NCI)
NantBioScience, Inc.
Rain Oncology Inc
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Taiho Oncology, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins